Table 4.
Clinical characteristics of the CHB liver cirrhosis CC and DC group cases ().
| Clinical data | CC group | DC group | p |
|---|---|---|---|
| Male/female | 16/7 | 8/4 | 0.071 |
| Age (years old) | 50.8 ± 13.11 | 54.4 ± 7.39 | 0.388 |
| Blood cell counts (109/L) | 4.8 ± 1.57 | 4.2 ± 1.87 | 0.430 |
| Hemoglobin (g/L) | 135 ± 27 | 107 ± 19 | 0.005 |
| Blood platelet (109/L) | 126 ± 26 | 85 ± 11 | 0.109 |
| ALT (U/L) | 76 ± 9.7 | 30 ± 9.4 | 0.181 |
| AST (U/L) | 58 ± 13 | 3.7 ± 0.64 | 0.0001 |
| γ-GT (U/L) | 62 ± 12 | 37 ± 7.5 | 0.086 |
| ALP (U/L) | 85 ± 12.6 | 100 ± 34.2 | 0.405 |
| T-Bil (μmol/L) | 18 ± 8.5 | 68 ± 7.5 | 0.043 |
| D-Bil (μmol/L) | 5.8 ± 3.3 | 44 ± 7.9 | 0.031 |
| TP (g/L) | 66 ± 8.6 | 62 ± 7.3 | 0.164 |
| ALB (g/L) | 37 ± 7.3 | 32 ± 4.4 | 0.050 |
| TC (U/L) | 3.8 ± 1.0 | 3.7 ± 0.6 | 0.775 |
| TG (U/L) | 1.0 ± 0.3 | 0.72 ± 0.24 | 0.001 |
| AFP | 52 ± 12 | 31 ± 9.3 | 0.459 |
| INR | 1.17 ± 0.21 | 1.91 ± 0.87 | 0.015 |
| HBV-DNA (107 U/L) | 9.8 ± 0.9 | 5.3 ± 0.7 | 0.782 |
| HBeAg-positive rate (%)∗ | 60% | 33% | 0.164 |